|
Venmax Drugs & Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
14.56 Cr.
|
P/BV
|
-22.06
|
Book Value (Rs.)
|
-1.26
|
|
52 Week High/Low (Rs.)
|
37/9
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
21/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -0.02 | 0.12 | 0.43 | 3.52 | -0.31 |
| Diluted EPS (Rs.) | -0.02 | 0.12 | 0.43 | 3.52 | -0.31 |
| Cash EPS (Rs.) | -0.01 | 0.13 | 0.44 | 3.54 | -0.29 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 8.42 | -1.24 | -1.36 | -1.79 | -5.32 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 8.42 | -1.24 | -1.36 | -1.79 | -5.32 |
| Revenue From Operations / Share (Rs.) | 1.54 | 0.00 | 0.00 | 0.00 | 0.32 |
| PBDIT / Share (Rs.) | -0.01 | 0.17 | 0.44 | 3.54 | -0.28 |
| PBIT / Share (Rs.) | -0.02 | 0.16 | 0.43 | 3.52 | -0.30 |
| PBT / Share (Rs.) | -0.02 | 0.16 | 0.43 | 3.52 | -0.30 |
| Net Profit / Share (Rs.) | -0.02 | 0.12 | 0.43 | 3.52 | -0.31 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -0.85 | 0.00 | 0.00 | 0.00 | -90.21 |
| PBIT Margin (%) | -1.64 | 0.00 | 0.00 | 0.00 | -96.37 |
| PBT Margin (%) | -1.74 | 0.00 | 0.00 | 0.00 | -96.37 |
| Net Profit Margin (%) | -1.30 | 0.00 | 0.00 | 0.00 | -96.77 |
| Return on Networth / Equity (%) | -0.23 | -9.92 | -31.57 | -196.39 | 0.00 |
| Return on Capital Employeed (%) | -0.30 | -13.46 | -31.79 | -197.39 | 5.81 |
| Return On Assets (%) | -0.20 | 79.23 | 106.71 | 864.27 | -52.82 |
| Total Debt / Equity (X) | 0.01 | -0.54 | -0.49 | -0.37 | -0.83 |
| Asset Turnover Ratio (%) | 0.30 | 0.00 | 0.00 | 0.00 | 0.44 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 6.78 | 0.02 | 0.15 | 0.11 | 0.07 |
| Quick Ratio (X) | 6.70 | 0.02 | 0.15 | 0.11 | 0.07 |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.72 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -8.63 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (%) | -12.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 12.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 15.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | -1812.83 | 0.00 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 18.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 3.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 18.52 | 0.00 | 0.00 | 0.00 | 0.00 |
